New Zealand markets open in 8 hours 16 minutes

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
284.00-1.63 (-0.57%)
At close: 04:00PM EDT
284.00 0.00 (0.00%)
After hours: 04:49PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Cash flows from operating activities
Net income
272,051
272,051
140,410
229,296
96,072
Depreciation & amortisation
101,069
101,069
87,747
82,737
78,171
Deferred income taxes
6,816
6,816
-27,431
13,130
-13,582
Stock-based compensation
42,183
42,183
48,982
32,367
32,280
Change in working capital
-
-69,517
29,263
-5,246
-27,751
Inventory
-32,007
-32,007
-7,140
-14,861
-13,647
Accounts payable
12,741
12,741
19,091
10,343
6,101
Other working capital
280,364
280,364
307,863
153,473
156,208
Other non-cash items
-22,637
-22,637
6,139
-9,540
4,064
Net cash provided by operating activities
325,272
325,272
352,164
205,217
181,619
Cash flows from investing activities
Investments in property, plant and equipment
-44,908
-44,908
-44,301
-51,744
-25,411
Acquisitions, net
0
0
-225,908
0
-289,492
Purchases of investments
-77,998
-77,998
-39,684
-70,187
-43,475
Sales/maturities of investments
26,055
26,055
66,377
147,120
21,579
Other investing activities
-26,943
-26,943
-
-
-
Net cash used for investing activities
-96,851
-96,851
-243,516
27,095
-336,799
Cash flows from financing activities
Debt repayment
-175,500
-175,500
-271,500
-188,500
-413,500
Common stock repurchased
-160,950
-160,950
-43,178
-50,112
-15,405
Dividends paid
-50,185
-50,185
-49,622
-48,902
-48,364
Other financing activities
-23,373
-23,373
-19,343
-7,271
-6,297
Net cash used provided by (used for) financing activities
-242,853
-242,853
-62,551
-183,803
134,384
Net change in cash
-26,524
-26,524
52,466
45,739
-21,104
Cash at beginning of period
199,091
199,091
146,625
100,886
121,990
Cash at end of period
172,567
172,567
199,091
146,625
100,886
Free cash flow
Operating cash flow
325,272
325,272
352,164
205,217
181,619
Capital expenditure
-44,908
-44,908
-44,301
-51,744
-25,411
Free cash flow
280,364
280,364
307,863
153,473
156,208